Abilify


Also found in: Medical, Wikipedia.
Related to Abilify: Seroquel, Cymbalta

A·bil·i·fy

 (ə-bĭl′ə-fī′)
A trademark for the drug aripiprazole.
References in periodicals archive ?
Otsuka) today announced marketing authorisation approval from the European Commission for Abilify Maintena (aripiprazole), an intramuscular (IM) once-monthly injectable formulation for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
s (New York) earnings beat analysts' estimates on lower costs from job cuts and outsourcing and higher sales of mood stabilizing drug Abilify and blood thinner Plavix.
M2 EQUITYBITES-April 29, 2015-Teva unveils generic atypical antipsychotic Abilify tablets in the US
Otsuka) today announced a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorisation for Abilify Maintena (aripiprazole), an intramuscular (IM) depot formulation for the maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
NEW YORK -- Use of antipsychotic medications such as Abilify and Risperdal to control youngsters with attention-deficit/hyperactivity disorder (ADHD) and other behavior problems has skyrocketed in recent years, a new study finds.
Aripiprazole lauroxil is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY.
The deal will enable Otsuka to expand its portfolio shortly before patent protection for the oral version of its popular drug, the schizophrenia treatment Abilify (OPC-14597) jointly promoted with Bristol-Myers Squibb, ends in 2015.
Genetics are also having an impact on sales of atypical antipsychotics, also used to treat bipolar disorder, including AstraZeneca/Astella's Seroquel, Eli Lilly's Zyprexa, Pfizer's Geodon Bristol-Myers Squibb/Otsuka Pharmaceutical's Abilify.
s (New York) profit topped analysts' estimates as sales rose for the mood-stabilizing drug Abilify and the blood thinner Plavix.